Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

liver adenomatosis - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

liver adenomatosis

MONDO:0035447

Also known as:Hepatic adenomatosis

Overview

A rare neoplastic disease characterized by the presence of ten or more hepatocellular adenomas in a background of normal appearing hepatic parenchyma. The majority of reported cases are female. There is no association with steroid use. The condition is considered benign, although the risk of complications (such as malignant transformation or spontaneous rupture with intraperitoneal hemorrhage) is much higher than in isolated hepatic adenoma. Hepatocellular carcinoma develops in less than 10% of cases.

ResearchLimited published research (8 articles)

Prognosis

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for liver adenomatosis.

8 publications have been identified in PubMed for liver adenomatosis. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (38%), and Basic Science / Preclinical (13%).

Recent Publications

Garbarine IC (2026). [PMID: 41680345](https://pubmed.ncbi.nlm.nih.gov/41680345/). *J Gastrointest Cancer*. [Review / Meta-Analysis]
Shreenath AP (2026). [PMID: 30020636](https://pubmed.ncbi.nlm.nih.gov/30020636/). *Unknown Journal*. [Review / Meta-Analysis]
Segatt PH (2025). [PMID: 40577161](https://pubmed.ncbi.nlm.nih.gov/40577161/). *Medicina (B Aires)*. [Review / Meta-Analysis]
Sjöholm Å (2025). [PMID: 41475867](https://pubmed.ncbi.nlm.nih.gov/41475867/). *BMJ Case Rep*. [Case Report / Case Series]
Alvarez J (2024). [PMID: 38862365](https://pubmed.ncbi.nlm.nih.gov/38862365/). *Transplant Proc*. [Case Report / Case Series]
Huang Y (2024). [PMID: 39262622](https://pubmed.ncbi.nlm.nih.gov/39262622/). *ACG Case Rep J*. [Case Report / Case Series]

Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 9:19 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:566841

GARD

Genetic and Rare Diseases Info Center

GARD:22278

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

liver adenomatosis

Overview

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team